AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
114.67
-3.32 (-2.81%)
May 15, 2026, 4:00 PM EDT - Market closed
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 1.77B | 1.74B | 1.64B | | | | | | | | | | | | |
Aptar Pharma Revenue Growth | 1.67% | 5.74% | 8.03% | | | | | | | | | | | | |
| 1.37B | 1.31B | 1.23B | | | | | | | | | | | | |
Aptar Beauty Revenue Growth | 4.42% | 6.83% | -3.31% | | | | | | | | | | | | |
| 738.81M | 730.26M | 714.01M | | | | | | | | | | | | |
Aptar Closures Revenue Growth | 1.17% | 2.28% | 2.18% | | | | | | | | | | | | |
| -5.00K | -3.00K | 2.00K | | | | | | | | | | | | |
| 3.87B | 3.78B | 3.58B | | | | | | | | | | | | |
| 2.53% | 5.42% | 2.74% | | | | | | | | | | | | |
Adjusted EBITDA
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Aptar Pharma Adjusted EBITDA | 611.42M | 607.65M | 568.37M | | | | | | | | | | | | |
Aptar Pharma Adjusted EBITDA Growth | 0.62% | 6.91% | 13.08% | | | | | | | | | | | | |
Aptar Beauty Adjusted EBITDA | 162.12M | 158.77M | 159.91M | | | | | | | | | | | | |
Aptar Beauty Adjusted EBITDA Growth | 2.11% | -0.71% | -2.33% | | | | | | | | | | | | |
Aptar Closures Adjusted EBITDA | 112.87M | 116.48M | 114.14M | | | | | | | | | | | | |
Aptar Closures Adjusted EBITDA Growth | -3.09% | 2.05% | 10.08% | | | | | | | | | | | | |
Corporate & Other Adjusted EBITDA | -65.76M | -67.79M | -67.50M | | | | | | | | | | | | |
| -325.56M | -314.06M | -278.43M | | | | | | | | | | | | |
| 495.09M | 501.04M | 496.50M | | | | | | | | | | | | |
Operating Income (Total) Growth | -1.19% | 0.92% | 22.89% | | | | | | | | | | | | |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Aptar Pharma Core Sales Growth | 3.00% | 8.00% | | | | | | | | | | | | |
Aptar Beauty Core Sales Growth | 2.00% | -3.00% | | | | | | | | | | | | |
Aptar Closures Core Sales Growth | 1.00% | 3.00% | | | | | | | | | | | | |
| 2.00% | 3.00% | | | | | | | | | | | | |
Updated May 1, 2026. Data Source:
Fiscal.ai.